Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 2,864: | Line 2,864: | ||
"title" : "Intensive lipid lowering with atorvastatin in patients with stable coronary disease", | "title" : "Intensive lipid lowering with atorvastatin in patients with stable coronary disease", | ||
"pmid" : "15755765" | "pmid" : "15755765" | ||
}, | |||
{ | |||
"timestamp" : "2014-05-19T10:42:47Z", | |||
"briefDesignDescription" : "Spironolactone for HFpEF", | |||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa1313731", | |||
"pageid" : 1797, | |||
"pdfurl" : "http://www.nejm.org/doi/pdf/10.1056/NEJMoa1313731", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Pitt B, <i>et al</i>. \"Spironolactone for heart failure with preserved ejection fraction\". <i>The New England Journal of Medicine</i>. 2014. 370(15):1383-1392.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist", | |||
"briefResultsDescription" : "Spironolactone doesn't reduce CV mortality, aborted cardiac arrest or HF hospitalizations in HFpEF", | |||
"published" : "2014-04-20", | |||
"pageName" : "TOPCAT", | |||
"diseases" : "Heart Failure", | |||
"abbreviation" : "TOPCAT", | |||
"title" : "Spironolactone for heart failure with preserved ejection fraction", | |||
"pmid" : "24716680" | |||
}, | }, | ||
{ | { |